Overall Technical outlook

Price Summary

On 2025-09-05, Mankind Pharma Limited's stock opened at 2568.0, spiked to 2590.9, declined to 2543.8, and closed -0.68% down at 2550.6, with 176377 shares traded.
The top price for the stock in the last 52 weeks is 2998.4, with the bottom price being 2161.7.
The future price of MANKIND is anticipated to range from 2150.0 to 3300.0, with an expected mean price of 2794.2942, according to the recommendations of 17 analysts.

Technicals

Support and Resistance: The price sits at 2550.6, supported by 2415.05 and resisted by 2564.2. This indicates a trading range where 2415.05 provides a floor, preventing declines, and 2564.2 acts as a ceiling, limiting further price increases for MANKIND.
MANKIND supportResistance 9162e8
Support/Resistance for MANKIND


Aroon: The AROON is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
MANKIND aroon 9162e8
Aroon chart for Mankind Pharma Limited


Bol. Bands: The BOLL BANDS is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for MANKIND, with no strong trend emerging.
MANKIND bbands 9162e8
Bolinger Bands chart for Mankind Pharma Limited


Parabolic SAR: The PSAR maintains a bearish outlook for MANKIND, establishing a key resistance level that could limit further gains. This ongoing bearish trend suggests that the market may struggle to overcome this resistance, keeping upward movement subdued.
MANKIND psar 9162e8
Parabolic Stop and Reverse chart for Mankind Pharma Limited


Stochastic: The STOCHASTIC is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
MANKIND stoch 9162e8
Stochastic chart for Mankind Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
MANKIND trippleSMA 9162e8
Tripple SMA chart for Mankind Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.